Share

How COVID-19 is shaping Nigeria’s pharmaceutical industry

Meristem Securities says in the near term, lock-down measures employed worldwide could impede the ease of importing raw materials. Also, the congestion at Nigeria’s seaport has only gotten worse, posing potential risks to logistics costs. Eniola Olabode, Senior Investment Analyst at Meristem Securities joins CNBC Africa to breakdown the impact of the Covid-19 crisis on some key pharma stocks.

Mon, 15 Jun 2020 14:09:36 GMT
Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.